Brian Coblitz
About Brian Coblitz
Brian Coblitz serves as the Executive Director at The George Washington University Technology Commercialization Office and has extensive experience in biotechnology and intellectual property. He holds a PhD in Neuroscience and has worked in various roles at institutions such as Johns Hopkins University, Columbia University, and the National Institutes of Health.
Work at The George Washington University
Brian Coblitz serves as the Executive Director at The George Washington University, Technology Commercialization Office. He has held this position since 2012, contributing to the advancement of technology transfer and commercialization efforts within the university. His role involves overseeing initiatives that facilitate the transition of innovative research into marketable products, particularly in the life sciences sector.
Education and Expertise
Brian Coblitz earned his PhD in Neuroscience, Biochemistry, Cellular and Molecular Biology from The Johns Hopkins University School of Medicine, where he studied from 2002 to 2007. He also holds a BS in Cell and Molecular Biology from Tulane University, completed in 2002. Additionally, he has pursued further education in intellectual property management at New York University and completed a Certificate Program in Technology Transfer at the Foundation for Advanced Education in the Sciences.
Background in Research and Technology Transfer
Brian Coblitz has a diverse background in research and technology transfer. He began his career as a Research Technician at Washington University School of Medicine and Genome Sequencing Center in 2000 and 2001, respectively. He then worked as a Predoctoral Fellow at Johns Hopkins School of Medicine from 2002 to 2007, followed by a Postdoctoral Fellowship at Columbia University from 2007 to 2011. His experience includes a marketing internship at the National Institutes of Health, Office of Technology Transfer.
Professional Interests and Skills
Brian Coblitz has a strong interest in biotech licensing and commercialization, particularly focusing on small businesses. He possesses expertise in screening and performing due diligence for early-stage medical technology companies. His professional interests also extend to intellectual property marketing. He has specialized skills in molecular biology techniques, including microscopy and cell culture, which support his work in the life sciences.
Current Involvement in Investment
Since 2021, Brian Coblitz has been a member and angel investor at Life Science Angels, based in Rockville, Maryland. In this role, he focuses on investing in products such as small molecules, biologics, diagnostics, and medical devices, leveraging his extensive background in science and technology commercialization to identify promising opportunities in the life sciences sector.